[
    "{\"step_by_step_thinking\": \"Based on the provided documents, tirilazad has been extensively studied in the treatment of acute ischemic stroke. Multiple clinical trials have been conducted, and the results consistently show that tirilazad does not improve clinical outcome or reduce infarct volume in patients with acute ischemic stroke. In fact, some studies suggest that tirilazad may even worsen outcome and increase the rate of infusion site phlebitis. Therefore, the answer is B. no, tirilazad should not be used for the treatment of ischemic stroke.\", \"answer_choice\": \"B\"}"
]